[{"AccountsPayableCurrent_0_Q3_USD":51406000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":11920000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":539000.0,"PaymentsToAcquireEquityMethodInvestments_3_Q3_USD":30000000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1836000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-12401000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-13580000.0,"OtherLiabilitiesCurrent_0_Q3_USD":54292000.0,"OtherComprehensiveIncomeLossTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-600000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":1741000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":15514000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":10652000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":6312000.0,"OperatingIncomeLoss_3_Q3_USD":-480868000.0,"OperatingIncomeLoss_1_Q3_USD":-83205000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_3_Q3_USD":1797000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-492646000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-96412000.0,"NetIncomeLoss_3_Q3_USD":-492646000.0,"NetIncomeLoss_1_Q3_USD":-96412000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-396237000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":531446000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":820478000.0,"LongTermInvestments_0_Q3_USD":20801000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":170000000.0,"LiabilitiesCurrent_0_Q3_USD":112010000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":17077000.0,"ProceedsFromSaleOfShortTermInvestments_3_Q3_USD":743902000.0,"ValueAddedTaxReceivableNoncurrent_0_Q3_USD":23390000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense_3_Q3_USD":0.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"TreasuryStockValue_0_Q3_USD":3533000.0,"TreasuryStockShares_0_Q3_shares":27722.0,"TaxesPayableCurrentAndNoncurrent_0_Q3_USD":10989000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2916000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":1587930000.0,"ShortTermInvestments_0_Q3_USD":170000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":82.21,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q3_shares":7369767.0,"ShareBasedCompensation_3_Q3_USD":28106000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":149254000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":59002000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":100141000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":43103000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1206249000.0,"RestrictedCashNoncurrent_0_Q3_USD":743000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":401220000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":55144000.0,"ProvisionForDoubtfulAccounts_3_Q3_USD":5000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":37087000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":51592000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":6907000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":3000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":1728079000.0,"Liabilities_0_Q3_USD":140149000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":20070000.0,"CostOfRevenue_3_Q3_USD":30535000.0,"CostOfRevenue_1_Q3_USD":12162000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-493246000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-94671000.0,"CommonStockValue_0_Q3_USD":6000.0,"CommonStockSharesOutstanding_0_Q3_shares":95273589.0,"CommonStockSharesIssued_0_Q3_shares":95273589.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashEquivalentsAtCarryingValue_0_Q3_USD":301068000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":956382000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":1399241000.0,"CashAndDueFromBanks_0_Q3_USD":1097430000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1398498000.0,"AssetsCurrent_0_Q3_USD":1619087000.0,"Assets_0_Q3_USD":1728079000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":6000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":10556000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":2609000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2812830000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-15124000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":14505000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":3607000.0,"AccountsReceivableNetCurrent_0_Q3_USD":21018000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"DeferredRevenue_0_Q3_USD":17487000.0,"DepositsAssetsNoncurrent_0_Q3_USD":901000.0,"Depreciation_1_Q3_USD":1510000.0,"InvestmentIncomeInterest_3_Q3_USD":1171000.0,"InvestmentIncomeInterest_1_Q3_USD":713000.0,"InventoryWriteDown_3_Q3_USD":402000.0,"InventoryRawMaterials_0_Q3_USD":7196000.0,"InventoryNet_0_Q3_USD":12494000.0,"InventoryFinishedGoods_0_Q3_USD":5298000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":1678000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6142000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":23429000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-248000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":863000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":15858000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":95035432.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-11235000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":null,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-548000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-340000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":-492098000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":-96072000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-12000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":18926000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":695000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.34,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.01,"DepreciationDepletionAndAmortization_3_Q3_USD":4612000.0,"Depreciation_3_Q3_USD":4257000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":92174838.0,"Ticker":"ZLAB","CIK":"1704292","name":"ZAI LAB LTD","OfficialName":"Zai Lab Limited American Depositary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3400943056.0","Country":"China","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]